Related references
Note: Only part of the references are listed.Clinical performance of calcitonin and procalcitonin Elecsys® immunoassays in patients with medullary thyroid carcinoma
Luca Giovanella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Prediction of biochemical cure in patients with medullary thyroid cancer
A. Machens et al.
BRITISH JOURNAL OF SURGERY (2020)
Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center
Friedhelm Raue et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study
Else Marie Opsahl et al.
EUROPEAN THYROID JOURNAL (2019)
Measuring procalcitonin to overcome heterophilic-antibody-induced spurious hypercalcitoninemia
Luca Giovanella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules
Luca Giovanella et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen
Kosma Wolinski et al.
ENDOKRYNOLOGIA POLSKA (2017)
United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for Calcitonin
George J. Kahaly et al.
CLINICAL CHEMISTRY (2017)
Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years
Kyong Yeun Jung et al.
CLINICAL ENDOCRINOLOGY (2016)
Negative predictive value of procalcitonin in medullary thyroid carcinoma
Soo Kyung Lim et al.
ANNALES DE BIOLOGIE CLINIQUE (2016)
Medullary Thyroid Cancer With Undetectable Serum Calcitonin
Erika F. Brutsaert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Response to Initial Therapy Predicts Clinical Outcomes in Medullary Thyroid Cancer
Susan C. Lindsey et al.
THYROID (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
Utility of Serum Procalcitonin for Screening and Risk Stratification of Medullary Thyroid Cancer
Andreas Machens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Basal and Stimulated Calcitonin and Procalcitonin by Various Assays in Patients with and without Medullary Thyroid Cancer
Juergen Kratzsch et al.
CLINICAL CHEMISTRY (2011)
Procalcitonin Levels Predict Clinical Course and Progression-Free Survival in Patients With Medullary Thyroid Cancer
Martin A. Walter et al.
CANCER (2010)
Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules
Luca Giovanella et al.
CLINICAL ENDOCRINOLOGY (2010)
Procalcitonin: A Marker for the Diagnosis and Follow-Up of Patients with Medullary Thyroid Carcinoma
Alicia Algeciras-Schimnich et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Procalcitonin Can Be Used for Monitoring Sepsis in Patients with Medullary Thyroid Carcinoma
Alexander R. Novotny et al.
THYROID (2009)
Procalcitonin for the clinical laboratory: a review
Hans-Gerhard Schneider et al.
PATHOLOGY (2007)
Clinical review 167 -: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis:: A journey from calcitonin back to its precursors
KL Becker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Share Paper
